Skip to main content

Thank you for visiting nature.com. You are using a browser version with limited support for CSS. To obtain the best experience, we recommend you use a more up to date browser (or turn off compatibility mode in Internet Explorer). In the meantime, to ensure continued support, we are displaying the site without styles and JavaScript.

  • RESEARCH HIGHLIGHT

Antibody–drug teamwork tames deadly metastatic brain tumours

Brain cancer that has its roots in the breast stops growing, and even shrinks, after a hybrid therapy.
Coloured axial MRI scan through a brain with metastatic brain cancer

A 38-year-old woman’s brain cancer (pink patches) originated in a tumour in her breast. Some such brain cancers yield to a new treatment that yokes a drug to an antibody. Credit: Zephyr/Science Photo Library

A small trial has shown that a combination of an antibody therapy and an anticancer drug safely treats an aggressive brain cancer that starts in the breast1. The trial also suggests that the treatment is effective.

Access options

Rent or buy this article

Get just this article for as long as you need it

$39.95

Learn more

Prices may be subject to local taxes which are calculated during checkout

Nature 608, 452 (2022)

doi: https://doi.org/10.1038/d41586-022-02131-x

References

  1. Bartsch, R. et al. Nature Med. https://doi.org/10.1038/s41591-022-01935-8 (2022).

    Article  Google Scholar 

Download references

Subjects

Latest on:

Nature Careers

Jobs

Nature Briefing

Sign up for the Nature Briefing newsletter — what matters in science, free to your inbox daily.

Get the most important science stories of the day, free in your inbox. Sign up for Nature Briefing

Search

Advanced search

Quick links